메뉴 건너뛰기




Volumn 70, Issue 20, 2017, Pages 2476-2486

Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes

Author keywords

ejection fraction; heart failure; outcomes; survival

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE;

EID: 85032661539     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2017.08.074     Document Type: Article
Times cited : (704)

References (26)
  • 1
    • 78651478726 scopus 로고    scopus 로고
    • Epidemiology and risk profile of heart failure
    • Bui, A.L., Horwich, T.B., Fonarow, G.C., Epidemiology and risk profile of heart failure. Nat Rev Cardiol 8 (2010), 30–41.
    • (2010) Nat Rev Cardiol , vol.8 , pp. 30-41
    • Bui, A.L.1    Horwich, T.B.2    Fonarow, G.C.3
  • 2
    • 84871051576 scopus 로고    scopus 로고
    • Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
    • Vos, T., Flaxman, A.D., Naghavi, M., et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380 (2012), 2163–2196.
    • (2012) Lancet , vol.380 , pp. 2163-2196
    • Vos, T.1    Flaxman, A.D.2    Naghavi, M.3
  • 3
    • 84875420652 scopus 로고    scopus 로고
    • National trends in heart failure hospital stay rates, 2001 to 2009
    • Chen, J., Dharmarajan, K., Wang, Y., Krumholz, H.M., National trends in heart failure hospital stay rates, 2001 to 2009. J Am Coll Cardiol 61 (2013), 1078–1088.
    • (2013) J Am Coll Cardiol , vol.61 , pp. 1078-1088
    • Chen, J.1    Dharmarajan, K.2    Wang, Y.3    Krumholz, H.M.4
  • 4
    • 84945191651 scopus 로고    scopus 로고
    • Heart failure preserved ejection fraction (HFpEF): an integrated and strategic review
    • Lekavich, C.L., Barksdale, D.J., Neelon, V., Wu, J.R., Heart failure preserved ejection fraction (HFpEF): an integrated and strategic review. Heart Fail Rev 20 (2015), 643–653.
    • (2015) Heart Fail Rev , vol.20 , pp. 643-653
    • Lekavich, C.L.1    Barksdale, D.J.2    Neelon, V.3    Wu, J.R.4
  • 5
    • 84863614614 scopus 로고    scopus 로고
    • Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes
    • Steinberg, B.A., Zhao, X., Heidenreich, P.A., et al. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes. Circulation 126 (2012), 65–75.
    • (2012) Circulation , vol.126 , pp. 65-75
    • Steinberg, B.A.1    Zhao, X.2    Heidenreich, P.A.3
  • 6
    • 84884294190 scopus 로고    scopus 로고
    • 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
    • Yancy, C.W., Jessup, M., Bozkurt, B., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62 (2013), e147–e239.
    • (2013) J Am Coll Cardiol , vol.62 , pp. e147-e239
    • Yancy, C.W.1    Jessup, M.2    Bozkurt, B.3
  • 7
    • 33746033433 scopus 로고    scopus 로고
    • Outcome of heart failure with preserved ejection fraction in a population-based study
    • Bhatia, R.S., Tu, J.V., Lee, D.S., et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355 (2006), 260–269.
    • (2006) N Engl J Med , vol.355 , pp. 260-269
    • Bhatia, R.S.1    Tu, J.V.2    Lee, D.S.3
  • 8
  • 9
    • 84867175641 scopus 로고    scopus 로고
    • Mortality in heart failure with preserved ejection fraction: an unacceptably high rate
    • Burkhoff, D., Mortality in heart failure with preserved ejection fraction: an unacceptably high rate. Eur Heart J 33 (2012), 1718–1720.
    • (2012) Eur Heart J , vol.33 , pp. 1718-1720
    • Burkhoff, D.1
  • 10
    • 84980396108 scopus 로고    scopus 로고
    • 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
    • Ponikowski, P., Voors, A.A., Anker, S.D., et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 37 (2016), 2129–2200.
    • (2016) Eur Heart J , vol.37 , pp. 2129-2200
    • Ponikowski, P.1    Voors, A.A.2    Anker, S.D.3
  • 11
    • 84908367057 scopus 로고    scopus 로고
    • Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population
    • Cheng, R.K., Cox, M., Neely, M.L., et al. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population. Am Heart J 168 (2014), 721–730.e3.
    • (2014) Am Heart J , vol.168 , pp. 721-730.e3
    • Cheng, R.K.1    Cox, M.2    Neely, M.L.3
  • 12
    • 7044223312 scopus 로고    scopus 로고
    • The American Heart Association Get With The Guidelines program
    • Smaha, L.A., The American Heart Association Get With The Guidelines program. Am Heart J 148:Suppl 5 (2004), S46–S48.
    • (2004) Am Heart J , vol.148 , pp. S46-S48
    • Smaha, L.A.1
  • 13
  • 14
    • 85032690784 scopus 로고    scopus 로고
    • National Vital Statistics Reports: United States Life Tables, 2007. September 28, 2011., No. 9. Available at: Accessed September 19.
    • Arias E. National Vital Statistics Reports: United States Life Tables, 2007. September 28, 2011. Vol. 59, No. 9. Available at: https://www.cdc.gov/nchs/data/nvsr/nvsr59/nvsr59_09.pdf. Accessed September 19, 2017.
    • (2017) , vol.59
    • Arias, E.1
  • 15
    • 79952829685 scopus 로고    scopus 로고
    • Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment
    • Borlaug, B.A., Paulus, W.J., Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J 32 (2011), 670–679.
    • (2011) Eur Heart J , vol.32 , pp. 670-679
    • Borlaug, B.A.1    Paulus, W.J.2
  • 16
    • 84952700655 scopus 로고    scopus 로고
    • Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: a systematic review and meta-analysis of death and adverse outcomes
    • Kotecha, D., Chudasama, R., Lane, D.A., Kirchhof, P., Lip, G.Y.H., Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: a systematic review and meta-analysis of death and adverse outcomes. Int J Cardiol 203 (2016), 660–666.
    • (2016) Int J Cardiol , vol.203 , pp. 660-666
    • Kotecha, D.1    Chudasama, R.2    Lane, D.A.3    Kirchhof, P.4    Lip, G.Y.H.5
  • 17
    • 57349142933 scopus 로고    scopus 로고
    • Irbesartan in patients with heart failure and preserved ejection fraction
    • Massie, B.M., Carson, P.E., McMurray, J.J., et al. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 359 (2008), 2456–2467.
    • (2008) N Engl J Med , vol.359 , pp. 2456-2467
    • Massie, B.M.1    Carson, P.E.2    McMurray, J.J.3
  • 18
    • 77953630575 scopus 로고    scopus 로고
    • Executive summary: HFSA 2010 comprehensive heart failure practice guideline
    • Lindenfeld, J., Albert, N.M., Boehmer, J.P., et al. Executive summary: HFSA 2010 comprehensive heart failure practice guideline. J Card Fail 16 (2010), 475–539.
    • (2010) J Card Fail , vol.16 , pp. 475-539
    • Lindenfeld, J.1    Albert, N.M.2    Boehmer, J.P.3
  • 19
    • 70349948833 scopus 로고    scopus 로고
    • Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD)
    • Tsuchihashi-Makaya, M., Hamaguchi, S., Kinugawa, S., et al. Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). Circ J 73 (2009), 1893–1900.
    • (2009) Circ J , vol.73 , pp. 1893-1900
    • Tsuchihashi-Makaya, M.1    Hamaguchi, S.2    Kinugawa, S.3
  • 20
    • 84866768164 scopus 로고    scopus 로고
    • Hospitalization for congestive heart failure: United States, 2000-2010
    • Hall, M.J., Levant, S., DeFrances, C.J., Hospitalization for congestive heart failure: United States, 2000-2010. NCHS Data Brief 108 (2012), 1–8.
    • (2012) NCHS Data Brief , vol.108 , pp. 1-8
    • Hall, M.J.1    Levant, S.2    DeFrances, C.J.3
  • 21
    • 0031031212 scopus 로고    scopus 로고
    • Readmission after hospitalization for congestive heart failure among Medicare beneficiaries
    • Krumholz, H.M., Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med 157 (1997), 99–104.
    • (1997) Arch Intern Med , vol.157 , pp. 99-104
    • Krumholz, H.M.1
  • 22
    • 41149164312 scopus 로고    scopus 로고
    • Incident heart failure hospitalization and subsequent mortality in chronic heart failure: a propensity-matched study
    • Ahmed, A., Allman, R.M., Fonarow, G.C., et al. Incident heart failure hospitalization and subsequent mortality in chronic heart failure: a propensity-matched study. J Card Fail 14 (2008), 211–218.
    • (2008) J Card Fail , vol.14 , pp. 211-218
    • Ahmed, A.1    Allman, R.M.2    Fonarow, G.C.3
  • 23
    • 84880159174 scopus 로고    scopus 로고
    • Targeting the renin–angiotensin–aldosterone system in heart failure
    • Lang, C.C., Struthers, A.D., Targeting the renin–angiotensin–aldosterone system in heart failure. Nat Rev Cardiol 10 (2013), 125–134.
    • (2013) Nat Rev Cardiol , vol.10 , pp. 125-134
    • Lang, C.C.1    Struthers, A.D.2
  • 24
    • 84888212540 scopus 로고    scopus 로고
    • The renin-angiotensin-aldosterone system and heart failure
    • Sayer, G., Bhat, G., The renin-angiotensin-aldosterone system and heart failure. Cardiol Clin 32 (2014), 21–32.
    • (2014) Cardiol Clin , vol.32 , pp. 21-32
    • Sayer, G.1    Bhat, G.2
  • 25
    • 84975698839 scopus 로고    scopus 로고
    • Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME trial
    • Fitchett, D., Zinman, B., Wanner, C., et al. Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME trial. Eur Heart J 37 (2016), 1526–1534.
    • (2016) Eur Heart J , vol.37 , pp. 1526-1534
    • Fitchett, D.1    Zinman, B.2    Wanner, C.3
  • 26
    • 84855351349 scopus 로고    scopus 로고
    • Representativeness of the get with the guidelines-stroke registry: comparison of patient and hospital characteristics among Medicare beneficiaries hospitalized with ischemic stroke
    • Reeves, M.J., Fonarow, G.C., Smith, E.E., et al. Representativeness of the get with the guidelines-stroke registry: comparison of patient and hospital characteristics among Medicare beneficiaries hospitalized with ischemic stroke. Stroke 43 (2012), 44–49.
    • (2012) Stroke , vol.43 , pp. 44-49
    • Reeves, M.J.1    Fonarow, G.C.2    Smith, E.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.